PharmOptima

Executive Summary

PharmOptima is a full-service contract research organization (CRO) and a proud member of Genesis Drug Discovery & Development (GD3). Founded in 2003 and headquartered in Portage, Michigan, the company provides integrated drug discovery and development services spanning from target identification through IND filing and management of Phase I-III clinical trials. By leveraging expertise in small molecules and drug delivery, PharmOptima supports pharmaceutical and biotechnology clients in advancing their pipelines efficiently. As a private, preclinical-stage CRO, the firm benefits from GD3's broader network and resources, enhancing its ability to offer end-to-end solutions. While specific financials and recent milestones are not publicly disclosed, PharmOptima's long-standing presence and comprehensive service offerings position it as a reliable partner in the competitive CRO landscape.